Sernova secures ODD and RPDD for Haemophilia A programme
Sernova has secured ODD and rare paediatric disease designation (RPDD) from the US Food and Drug Administration (FDA) for its Haemophilia A programme.
📰 Cell Pouch News
Page 2 - Cell Pouch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Pouch. Real-time updates on events, politics, business and more.
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress - Sernova (OTC:SEOVF)
LONDON, Ontario and WINDHAM COUNTY, Conn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced an update on
Source: benzinga.com
Sernova (OTCMKTS:SEOVF) Stock Price Down 3.6%
Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) fell 3.6% during mid-day trading on Tuesday . The stock traded as low as $0.52 and last traded at $0.53. 5,630 shares were traded during mid-day trading, a decline of 72% from the average session volume of 20,293 shares. The stock had previously closed at $0.55. Sernova Stock […]
Source: wkrb13.com
Sernova (OTCMKTS:SEOVF) Trading Down 3.6%
Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) shares fell 3.6% on Tuesday . The company traded as low as $0.52 and last traded at $0.53. 5,630 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 20,293 shares. The stock had previously closed at $0.55. Sernova Stock Performance The […]
Source: tickerreport.com
Sernova (TSE:SVA) Shares Down 3.7%
Shares of Sernova Corp. (TSE:SVA – Get Free Report) fell 3.7% during trading on Thursday . The stock traded as low as C$0.77 and last traded at C$0.78. 107,203 shares traded hands during trading, an increase of 4% from the average session volume of 103,225 shares. The stock had previously closed at C$0.81. Sernova Trading […]
Source: wkrb13.com
Sernova (TSX:SVA) stock is cheap, Research Capital says
Following the release of new data on a core offering, Research Capital analyst Andre Uddin remains upbeat about the prospects of Sernova.
United States Cynthia Pussinen Andre Uddin American Thyroid Association Research Capital Sernova Stock Quote
Source: cantechletter.com
Sernova Presents Compelling New Data on the Cell Pouch
Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment for post-operative hypothyroidism...
Source: globenewswire.com
Sernova Corp. Announces New Preclinical Data for its Novel Cell Therapy Platform, Cell Pouch System, as Potential Treatment for Post-Operative Hypothyroidism at 2023 American Thyroid Association Annual Meeting
Sernova Corp. announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a potential treatment for post-operative hypothyroidism at the 2023 American Thyroid...
United States Sernova Corp American Thyroid Association Cell Pouch System Thyroid Association Annual Meeting
Source: marketscreener.com
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September
Issuer: Sernova Corp. / Key word(s): Conference/Miscellaneous14.09.2023 / 22:06 CET/CESTThe issuer is solely responsible for the content of this announcement.LONDON, Ontario; WINDHAM COUNTY, Connecticut – September 14, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader...
Source: pharmiweb.com
SVA stock has an upside of 369%, Echelon says
Its third quarter results are out the door and Echelon analyst Stefan Quenneville thinks there is a lot of money to be made on Sernova Corp
Stefan Quenneville Cynthia Pussinen Sernova Corp Stock Sernova Corp Sernova Corp Stock Quote Cell Pouch
Source: cantechletter.com